SOMATOSTATIN RECEPTOR POSITIVE
Clinical trials for SOMATOSTATIN RECEPTOR POSITIVE explained in plain language.
Never miss a new study
Get alerted when new SOMATOSTATIN RECEPTOR POSITIVE trials appear
Sign up with your email to follow new studies for SOMATOSTATIN RECEPTOR POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Alpha' radiation therapy tested for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new targeted radiation drug for adults whose gastrointestinal neuroendocrine tumors (GI NET) or adrenal tumors (pheochromocytoma/paragangliomas) have spread and cannot be removed by surgery, and have already been treated with a similar type of radiation th…
Matched conditions: SOMATOSTATIN RECEPTOR POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for kids with tough cancers: first trial of targeted radiation therapy
Disease control Recruiting nowThis early-stage study aims to find a safe and effective dose of a targeted radiation drug for children and teenagers with specific cancers that have come back or stopped responding to standard treatments. The therapy delivers radiation directly to cancer cells. Researchers will …
Matched conditions: SOMATOSTATIN RECEPTOR POSITIVE
Phase: PHASE1 • Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Radioactive 'Smart Bomb' drug trial seeks to shrink tough cancers
Disease control Recruiting nowThis early-stage trial is testing a new drug that delivers radiation directly to cancer cells in people with advanced tumors that have spread and cannot be removed by surgery. The treatment targets a specific protein found on several cancer types, including some lung, kidney, hea…
Matched conditions: SOMATOSTATIN RECEPTOR POSITIVE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC